Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples